Recent Years Saw Increase in U.S. Pregnancy-Related Deaths
By Elana Gotkine HealthDay Reporter
FRIDAY, April 18, 2025 -- During 2018 to 2022, pregnancy-related deaths in the United States increased, according to a study published online April 9 in JAMA Network Open.
Yingxi Chen, M.D., Ph.D., from the National Cancer Institute in Rockville, Maryland, and colleagues examined the age-standardized national rates of pregnancy-related death from 2018 to 2022 in the United States using data from the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research.
There were 6,283 pregnancy-related deaths, including 1,891 late maternal deaths during 2018 to 2022. The researchers found that there was an increase in the age-standardized annual and aggregated rate of pregnancy-related mortality (ASR) by 27.7 percent from 2018 to 2022 (25.3 to 32.6 deaths per 100,000 live births). The increase was seen across age groups and was disproportionately driven by deaths among women aged 25 to 39 years (by 36.8 percent). Considerable variation was seen in rates by state, from 18.5 to 59.7 deaths per 100,000 live births. Overall, 2,679 pregnancy-related deaths could have been prevented from 2018 to 2022 if the national rate was reduced to the lowest state rate. The highest ASR was seen in American Indian and Alaska Native women, followed by non-Hispanic Black women (106.3 and 76.9 deaths per 100,000 live births, respectively). Mental and behavior disorders and drug-induced and alcohol-induced death were important contributing causes of late maternal death, although cardiovascular disease was the leading cause of the overall pregnancy-related deaths.
"Our analysis provides important insights that should inform the shared goal of preventing avoidable pregnancy-related deaths in the United States," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-19 06:00
Read more

- FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
- Everyday Digital Tech Is Protecting Seniors' Brain Health, Study Says
- FDA Approves Imfinzi (durvalumab) for Muscle Invasive Bladder Cancer
- Knee Replacement Recovery Time: What You Need To Know
- Local Outbreaks Can Motivate The Vaccine-Hesitant, Poll Finds
- ACP Issues Clinical Guideline for Pharmacologic Treatment of Acute Episodic Migraine
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions